AU
Nuo Therapeutics, Inc.
AURX · OTC
$1.30 +4.83% (+$0.06)
1M +21.50%
Market Cap $62.9M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
2/9Valuation
0 /100
Expensive P/S 12.10x
EV/EBITDA N/A
P/B N/A
Growth
100 /100
Growing Rev. growth 209.05%
FCF growth N/A
Book val. growth N/A
Profitability
20 /100
Weak Net margin 38.70%
Op. margin 33.32%
FCF margin 47.06%
Quality
21 /100
Poor ROA 76.63%
Asset turnover 1.98x
ROIC 153.00%
Debt
24 /100
High Int. coverage -25.05x
Current ratio 1.28x
Net debt/EBITDA N/A
Stability
40 /100
Moderate Rev. volatility 178.40%
EPS volatility 19.63%
Profitable years 0
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na AURX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
David E. Jorden
Employees
10
Headquarters
Houston
Nadcházející události
02 PRO
Earnings
Upcoming earnings report